Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimester

17 Feb 2025

Abstract excerpt

INTRODUCTION: Decisions concerning nuchal translucency (NT) between 3.0 and 3.4 mm remain controversial, particularly regarding whether to first calculate the combined first trimester screening test or to proceed directly with invasive testing. The literature suggests an increased risk of chromosomal aberration, as well as pathogenic copy number variations (CNVs) on chromosomal microarray, for fetuses with NT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39962853
DOI: 10.1111/aogs.15055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimesterPMID 39962853Read ↗

Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic OutcomesSemantic proximity Read ↗

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35Semantic proximity Read ↗

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature reviewSemantic proximity Read ↗

Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mmSemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Increased Nuchal Translucency in Fetuses with a Crown-Rump Length ≤ 45 mm: Clinical Outcomes and Diagnostic ImplicationsSemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Molecular genetic and pregnancy outcomes of fetuses with increased Nuchal Translucency.Semantic proximity Read ↗

Abnormal Nuchal Translucency and Outcomes of Singleton Pregnancies (Antop) Study: An 8 -year Retrospective Cohort AnalysisSemantic proximity Read ↗

Combined Application of Chromosome Karyotype and Microarray Analysis in Fetus With Increased Nuchal TranslucencySemantic proximity Read ↗

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotypeSemantic proximity Read ↗

Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.